Sign in

CIK 0001472012

  • Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770694340
Phone
+1 610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$334,224
in 1 filing, $334K under 10b5-1 plans

Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Higgins Jack −$334K Chief Scientific Officer sold 17% of stake
Date Insider Transaction Shares Price Value Owned after
2023-06-08 Lefenfeld Michael Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-06-08 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-06-08 BARON RICHARD A Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-06-08 PRENDERGAST FRANKLYN G Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-06-08 WAGENHEIM PHILIP Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-06-08 Giesing Dennis H Chief Development Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2023-01-15 WAGENHEIM PHILIP Director Grant or award +8,750 $4.00 $35K 406,147
2023-01-15 LAMATTINA JOHN L Director Grant or award +15,125 $4.00 $61K 66,953
2023-01-15 Lefenfeld Michael Director Grant or award +13,875 $4.00 $56K 40,747
2023-01-15 RAPP MICHAEL Director Grant or award +17,500 $4.00 $70K 817,366
2022-06-16 Stoneman Sandra G. General Counsel and CLO Grant or award · Stock Option (Right to Buy) +43,000 43,000
2022-06-16 Sarma Purnanand D President and CEO Grant or award · Stock Option (Right to Buy) +121,000 121,000
2022-06-16 Roche Corleen M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2022-06-16 ROBINSON MATTHEW K Chief Technology Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2022-06-16 Giesing Dennis H Chief Development Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2022-06-16 WAGENHEIM PHILIP Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2022-06-16 RAPP MICHAEL Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2022-06-16 PRENDERGAST FRANKLYN G Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2022-06-16 Lefenfeld Michael Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2022-06-16 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +6,500 6,500

Page 9 of 12 · 240 trades